Aramark (NYSE:ARMK) Surprises With Q2 CY2026 Sales

Aramark (NYSE:ARMK) reported Q2 CY2026 revenue of $5.06 billion, up 9.3% year over year and 2.4% above Wall Street estimates, according to the company. Non-GAAP adjusted EPS was $0.52, up from $0.40 a year earlier, beating consensus by 7.2%. Analysts expect full-year EPS to rise to $2.57 from $2.09.

Original reporting
Published Aug 11, 2026, 11:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 11, 2026, 12:41 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Aramark (NYSE:ARMK) Surprises With Q2 CY2026 Sales — source image
Decision brief

The 30-second read

$ARMKBullishMed
01

Why it matters

The quarter shows a clear earnings beat (adjusted EPS $0.52 vs $0.40 prior year, 7.2% above estimates) and revenue beat ($5.06B, 2.4% above estimates), while profitability appears stable (adjusted operating margin 4.3%).

02

Market read

Traders can reassess near-term expectations for Aramark’s earnings trajectory given the reported beat, but margin stability may cap the magnitude of re-rating.

03

What to watch

The article cites forward EPS growth (to $2.57) but does not provide detailed guidance drivers or cash flow, so traders may need to verify whether working capital or one-offs supported the quarter.

Relevance 7/10Novelty 7/10Timing: post-Q2 results, same-day reaction noted as stock flat at $55.74 immediately after reporting

Background

Aramark is a food and facilities services provider reporting Q2 CY2026 results with revenue growth and adjusted profitability metrics.

Company-level read

Ticker impact

$ARMKBullishMedium confidence
Context

Aramark reported Q2 CY2026 revenue of $5.06B (+9.3% YoY) and adjusted EPS of $0.52, both beating consensus.

Expected impact

Likely modest positive follow-through versus peers, but upside may fade if guidance or margins do not improve further.

Evidence & confidence

The article provides concrete beat figures (revenue +2.4% vs estimates, EPS +7.2% vs estimates) and notes adjusted operating margin was stable at 4.3%, limiting upside surprise from profitability expansion.

Market effects

Stable adjusted operating margin (4.3%) implies limited margin leverage for business services, tempering sector-wide multiple expansion.

No regional demand or FX details provided; impact likely confined to company-specific sentiment.

No global macro or cross-border contract details provided beyond operations in 16 countries.

Counterpoint

Stable adjusted operating margin (4.3% vs prior year) suggests the beat may be driven more by top-line than durable cost improvements, reducing the sustainability of the upside.

Key entities

  • Aramark

    Reported Q2 CY2026 revenue and adjusted EPS beats, with stable adjusted operating margin.

Related articles

$ARMKMedAI 8/10

Why Aramark (ARMK) Stock Is Up Today

Aramark (NYSE: ARMK) shares rose about 9.8% after the company reported better-than-expected Q3 2026 results. Revenue was $5.06B, up 9.3% year over year, and adjusted EPS was $0.52 above consensus. Free cash flow turned positive at $8.69M versus a $33.55M loss a year earlier, supporting investor sentiment.

$ARMKHighAI 9/10

Why is Aramark stock surging today?

Aramark (ARMK) shares rose about 8.3% after the company reported fiscal Q3 2026 adjusted EPS of $0.52 vs $0.48 consensus and revenue of $5.1B vs $4.92B forecast. Organic revenue grew 9% and adjusted operating income rose to $261M. Aramark raised FY26 organic revenue guidance to 9–10% and reaffirmed adjusted EPS growth of 20–25%.

$ARMKMed

Aramark Boosts FY26 Organic Revenue Growth - Update

Aramark (ARMK) reported third-quarter results and reaffirmed its FY2026 adjusted EPS growth outlook of 20% to 25%. It raised its FY2026 organic revenue growth forecast to 9% to 10% from the prior high-end 7% to 9%. The board approved a $0.12 quarterly dividend payable Sept. 9, 2026. ARMK was about $55 premarket.

$ARMKHigh

Aramark (ARMK): Results of Operations and Financial Condition

Aramark (ARMK) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex991armkq3fy2026.htm EX-99.1 Document For Immediate Release Inquiries: Felise Glantz Kissell (215) 409-7287 Kissell-Felise@aramark.com Gene Cleary (215) 409-7945 Cleary-Gene@aramark.com Aramark Reports Third Quarter Earnings YEAR-OVER-YEAR SUMMARY Note: As previously d

$ARMKMedAI 8/10

Aramark (ARMK) – Investment Analysts’ Weekly Ratings Updates

Aramark (NYSE: ARMK) saw multiple brokerages update ratings and price targets from mid-March to mid-May 2026. Bank of America raised its target to $59 (buy); RBC to $55 (outperform); Morgan Stanley to $50 (equal weight); UBS to $56 (buy); JPMorgan to $55 (overweight). Several others reaffirmed “buy” ratings. Aramark also declared a $0.12 quarterly dividend (ex-date May 20), $0.48 annualized, ~0.9% yield.